4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0000921895-24-001377
Options or other derivatives
- Director acquired 7,688 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| BVF PARTNERS L P/IL Director | 2024-06-06 | Grant or award · Option to Buy | +7,688 | 7,688 | I | ||
Loading xslF345X05/form407422010_06102024.xml…